348 related articles for article (PubMed ID: 32070547)
21. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
Vakilinezhad MA; Amini A; Dara T; Alipour S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
[TBL] [Abstract][Full Text] [Related]
22. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy.
Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH
Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494
[TBL] [Abstract][Full Text] [Related]
23. Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery.
Miao Y; Qiu Y; Yang W; Guo Y; Hou H; Liu Z; Zhao X
Colloids Surf B Biointerfaces; 2018 Sep; 169():313-320. PubMed ID: 29800906
[TBL] [Abstract][Full Text] [Related]
24. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
25. A pH-responsive sequential-disassembly nanohybrid for mitochondrial targeting.
Li L; Sun W; Li L; Liu Y; Wu L; Wang F; Zhou Z; Zhang Z; Huang Y
Nanoscale; 2017 Jan; 9(1):314-325. PubMed ID: 27910990
[TBL] [Abstract][Full Text] [Related]
26. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
27. Chain-Length- and Saturation-Tuned Mechanics of Fluid Nanovesicles Direct Tumor Delivery.
Dai Z; Yu M; Yi X; Wu Z; Tian F; Miao Y; Song W; He S; Ahmad E; Guo S; Zhu C; Zhang X; Li Y; Shi X; Wang R; Gan Y
ACS Nano; 2019 Jul; 13(7):7676-7689. PubMed ID: 31187973
[TBL] [Abstract][Full Text] [Related]
28. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
[TBL] [Abstract][Full Text] [Related]
29. Biological evaluation of mitochondria targeting small molecules as potent anticancer drugs.
Luo S; Dang X; Wang J; Yuan C; Hu Y; Lei S; Zhang Y; Lu D; Jiang F; Fu L
Bioorg Chem; 2021 Sep; 114():105055. PubMed ID: 34144278
[TBL] [Abstract][Full Text] [Related]
30. A surface convertible nanoplatform with enhanced mitochondrial targeting for tumor photothermal therapy.
Wang M; Ruan L; Zheng T; Wang D; Zhou M; Lu H; Gao J; Chen J; Hu Y
Colloids Surf B Biointerfaces; 2020 May; 189():110854. PubMed ID: 32086023
[TBL] [Abstract][Full Text] [Related]
31. Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer.
Cheng X; Li D; Sun M; He L; Zheng Y; Wang X; Tang R
Colloids Surf B Biointerfaces; 2019 Sep; 181():185-197. PubMed ID: 31132609
[TBL] [Abstract][Full Text] [Related]
32. Charge-Convertible Carbon Dots for Imaging-Guided Drug Delivery with Enhanced in Vivo Cancer Therapeutic Efficiency.
Feng T; Ai X; An G; Yang P; Zhao Y
ACS Nano; 2016 Apr; 10(4):4410-20. PubMed ID: 26997431
[TBL] [Abstract][Full Text] [Related]
33. pH-Driven Targeting Nanoprobe with Dual-Responsive Drug Release for Persistent Luminescence Imaging and Chemotherapy of Tumor.
Zhang HJ; Zhao X; Chen LJ; Yang CX; Yan XP
Anal Chem; 2020 Jan; 92(1):1179-1188. PubMed ID: 31818096
[TBL] [Abstract][Full Text] [Related]
34. Sequentially Triggered Delivery System of Black Phosphorus Quantum Dots with Surface Charge-Switching Ability for Precise Tumor Radiosensitization.
Chan L; Gao P; Zhou W; Mei C; Huang Y; Yu XF; Chu PK; Chen T
ACS Nano; 2018 Dec; 12(12):12401-12415. PubMed ID: 30407787
[TBL] [Abstract][Full Text] [Related]
35. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
[TBL] [Abstract][Full Text] [Related]
36. Novel Mitochondrial Targeting Multifunctional Surface Charge-Reversal Polymeric Nanoparticles for Cancer Treatment.
Fang L; Fan H; Guo C; Cui L; Zhang P; Mu H; Xu H; Zhao F; Chen D
J Biomed Nanotechnol; 2019 Nov; 15(11):2151-2163. PubMed ID: 31847930
[TBL] [Abstract][Full Text] [Related]
37. An investigation of antitumor efficiency of novel sustained and targeted 5-fluorouracil nanoparticles.
Le VM; Wang JJ; Yuan M; Nguyen TL; Yin GF; Zheng YH; Shi WB; Lang MD; Xu LM; Liu JW
Eur J Med Chem; 2015 Mar; 92():882-9. PubMed ID: 25676729
[TBL] [Abstract][Full Text] [Related]
38. A pH and reduction dual-sensitive polymeric nanomicelle for tumor microenvironment triggered cellular uptake and controlled intracellular drug release.
Su Z; Xu Y; Wang Y; Shi W; Han S; Shuai X
Biomater Sci; 2019 Aug; 7(9):3821-3831. PubMed ID: 31268075
[TBL] [Abstract][Full Text] [Related]
39. PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy.
Choi JY; Ramasamy T; Kim SY; Kim J; Ku SK; Youn YS; Kim JR; Jeong JH; Choi HG; Yong CS; Kim JO
Acta Biomater; 2016 Jul; 39():94-105. PubMed ID: 27163403
[TBL] [Abstract][Full Text] [Related]
40. Charge Reversible and Mitochondria/Nucleus Dual Target Lipid Hybrid Nanoparticles To Enhance Antitumor Activity of Doxorubicin.
Song YF; Liu DZ; Cheng Y; Teng ZH; Cui H; Liu M; Zhang BL; Mei QB; Zhou SY
Mol Pharm; 2018 Mar; 15(3):1296-1308. PubMed ID: 29432025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
